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Abstract
In recent years, total laparoscopic pancreaticoduodenectomy (TLPD) has been 
introduced as a feasible alternative to open pancreaticoduodenectomy (OPD) when 
performed by experienced surgeons in laparoscopic and pancreatic surgery. Its 
application has been gradually increased, but its safety, reproducibility, and oncologi-
cal outcomes are still debated due to its technical complexity and prolonged operating 
time. We performed a systematic analysis of the more relevant aspects of TLPD. In 
this chapter, we report a general overview of the different experiences present in the 
literature regarding indications, surgical techniques, postoperative outcomes, benefits 
and limitations of this approach, oncological results, learning curve, and costs. There 
is no standardized surgical technique for TLPD. Different techniques exist for both the 
demolitive stage and the reconstructive stage. We summarized the different aspects of 
the surgical technique based on the various experiences reported by different authors. 
Compared to OPD, TLPD provides the advantages of laparoscopy, i.e., reduced blood 
loss, decreased postoperative pain, and shorter length of hospital stay, without increas-
ing the rate of postoperative complications or compromising oncological outcomes. 
An appropriate patient selection is crucial at the beginning of the learning curve. With 
increased experience, more challenging cases may also be approached with this tech-
nique, including those requiring major vascular resections or multi-visceral resections.
Keywords: mini-invasive pancreaticoduodenectomy, laparoscopic 
pancreaticoduodenectomy, advanced laparoscopic surgery, pancreatic surgery
1. Introduction
Minimally invasive techniques in pancreatic surgery were initially used only for diag-
nostic and stadiative purposes, palliative procedures, or the drainage of cysts and the 
enucleation of small solid lesions [1, 2]. In the last 10 years, with advances in technology 
and surgical techniques, there has been a growing application of minimally invasive sur-
gery for the treatment of benign and malignant pancreatic neoplasms [3], and complex 
operations such as distal pancreatectomy (DP) and pancreaticoduodenectomy (PD) 
have started to be performed [2]. Laparoscopic distal pancreatectomy (LDP) does not 
require the execution of anastomosis, resulting in quite easy performance and achieving 
worldwide acceptance. On the other hand, the laparoscopic pancreaticoduodenectomy 
(LPD) has obtained a marginal acceptance until now, raising doubts about its safety and 
reproducibility, due to its technical complexity and prolonged operating time [3].
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Although the first LPD was performed by Gagner and Pomp more than 20 years 
ago for the treatment of a chronic pancreatitis involving the pancreatic head [4], the 
procedure had a slow diffusion [5], especially in comparison to the other applica-
tions of minimally invasive surgery in the field of oncological treatment [3].
This slow diffusion can be explained by three main reasons.
The first one is the technical complexity of LPD, especially due to the retroperi-
toneal position of the pancreas and the proximity to the duodenum and surround-
ing vascular structures; the fashioning of the laparoscopic anastomoses; and the 
laparoscopic dissection of the uncinate process from the large vessels [6–8].
The second one is the high complication rate of PD, heavily affecting postopera-
tive recovery; this represents a limit to the potential advantages of mini-invasive-
ness [9].
Finally, there is a lack of international consensus about the benefits regarding 
the feasibility and oncological efficacy of LPD [10].
However, in the last decade, the growing number of publications about laparo-
scopic pancreatic surgery seems to assess its feasibility and safety [3], especially if 
performed in highly experienced centers [11].
2. Indications
In all the cases where PD is indicated, laparoscopic approach can be theoretically 
applied:
• pancreatic adenocarcinoma
• symptomatic chronic pancreatitis
• neuroendocrine pancreatic tumors: functioning tumors, tumors with resect-
able metastases, tumors with diameters >2 cm, symptomatic nonfunctioning 
tumors, G3 with Ki67 > 20%, and neuroendocrine carcinoma
• cystic pancreatic tumors
• IPMN with high-risk stigmata (dilation of the Wirsung ≥10 mm, contrast-
enhancing solid intracystic component ≥5 mm, causing obstructive jaundice, 
with positive cytology)
• malignant tumors of the distal common bile duct
• malignant tumors of the ampulla of Vater
• malignant tumors of the duodenum
Since the learning curve for LPD is long, patients should be adequately selected. 
As reported in the literature [12], it is preferable to start with patients with low BMI 
and small ampullary tumors, duodenal adenocarcinomas, or tumors of the distal 
biliary tract and avoid ductal pancreatic adenocarcinomas because of their infiltra-
tive nature.
Accurate selection of patients is essential to decrease the rate of conversion and 
avoid unnecessary laparoscopic attempts, which would only increase the operative 
time and the risk of intraoperative complications.
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Suggested contraindications to LPD are significant comorbidities [1, 2, 13–15], 
previous upper-mesocolic abdominal surgeries [1, 14, 16, 17], and high BMI [17, 18].
On the contrary, age does not seem to be a contraindication. A study by Buchs 
et al. [13] compared LPD in patients younger and older than 70 years: post-opera-
tive outcomes in the two groups were similar, showing that age alone may not be a 
selection criterion for LPD.
Current studies about LPD are subject to high selection bias, since most centers 
are still in the learning curve and selecting only ideal candidates for the procedures.
A recent review by Wang et al. [19] analyzed studies that evaluated inclu-
sion and exclusion criteria for mini-invasive PD, reporting 14 studies that only 
mentioned inclusion criteria, 20 that only mentioned exclusion ones, and 13 that 
reported both. This review showed that patients selected for LPD had small peri-
ampullary tumors and low BMI. The most frequent contraindications were vascular 
invasion, previous upper-mesocolic procedures, and severe cardiovascular disease.
Indications and contraindications to LPD also depend on the experience of the 
surgical team [12]; with increased experience, it may also be performed for the treat-
ment of tumors involving surrounding organs or vascular structures, and almost 
all contraindications to LPD may become relative. In this scenario, some pioneering 
groups have also started performing venous resections during LPDs [7, 8].
However, the majority of authors consider as exclusion criteria: large tumors 
[1, 16], chronic pancreatitis, tumors involving the superior mesenteric-portal vein 
confluence, the superior mesenteric artery or the hepatic artery [12, 13], and neoad-
juvant radio-chemotherapy [20, 21], due to the local fibrosis caused by radiotherapy.
Many algorithms have been developed to help with LPD patient selection [22, 23].
3. Surgical technique
Currently, there is no consensus on the best surgical option for LPD, neither for 
the demolitive phase nor for the reconstructive one.
Differences in the surgical technique concern as follows:
• Preparatory phase: trocar placement, type of trocar used, access technique to 
peritoneum.
• Demolitive phase: surgical steps, devices and materials, pylorus preservation 
or not.
• Reconstructive phase: type of suture, anastomosis technique, surgical speci-
men extraction, drainages, stent placement in pancreatic duct to protect the 
pancreatico-jejunal anastomosis.
3.1 Preparatory phase
The number, type, and placement of trocars for LPD vary greatly throughout 
the literature. Most authors use 5 trocars (52.1%) [1, 24, 25]; some use 6 (30.4%) 
[26, 27]; more rarely, 4 [28, 29] or 7 [16] are used.
Pneumoperitoneum is usually induced using the “open” technique according to 
Hasson in periumbilical or supra-umbilical position [20, 24, 26, 28, 30], while rarely 
the “closed” technique with the Veress needle is used [1, 16, 27, 29].
Trocar placement varies between series, especially concerning the optic port 
and the port for the hepatic retractor. The optic port is more commonly placed in 
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the umbilical region (41.7%). The port for the hepatic retractor is, in many cases, 
placed along the midline in the subxiphoid region, while in some cases, it is placed 
along the right anterior axillary line, just under the hepatic ridge.
3.2 Demolitive phase
Boggi et al. [31] published a systematic review that analyzed various aspects of 
the demolitive phase. Their results are summarized in this section.
Concerning materials, the majority of authors used energy devices (678 patients, 
90.8% of cases). Some authors used a single energy device (in 10 cases ultrasonic 
shears, in 4 cases radiofrequency), while 8 used a dual energy device (6 ultrasound 
and radiofrequency, 1 ultrasound and bipolar, 1 ultrasound and monopolar).
The section of the pancreatic neck can be done using the ultrasonic shears, the 
electrocautery (104 patients, 15.9%), the stapler or ultrasonic shears (100 patients, 
15.3%), electrocautery or ultrasonic shears (65 patients, 9.9%), only stapler (12 
patients 1.8%), or only radiofrequency (6 patients, 0.9%) (Figures 1–3).
The method used to section the gastroduodenal artery is another relevant 
technical aspect, since the arterial stump is a frequent site of bleeding in case of 
pancreatic fistula.
Figure 2. 





In the majority of cases (274 patients, 54.5%), the use of clips was reported, 
while some authors (100 patients, 19.9%) reported only ligature. Other options are 
vascular stapler plus suture (1 article, 50 patients, 9.9%), clips plus suture (1 article, 
35 patients, 6.9%), vascular stapler only (1 article, 24 patients, 2.7%), and radiofre-
quency only (1 article, 11 patients, 2.1%) (Figures 4 and 5).
The specimen is often extracted via an umbilical (42.2%), supra-pubic (15.7%), 
or subxiphoid (15%) mini-laparotomy; other sites for extraction are sub-umbilical 
(8.9%), the right inferior quadrant (8.8%), or supraumbilical (4.9%) one.
Finally, the surgeon must decide whether to preserve the pylorus (Traverso-
Longmire intervention) or resect the gastric antrum (classic Whipple procedure).
Pylorus-preserving surgery is more commonly performed (55%) than gastric 
antrum resection among 21 authors (636 patients), 6 always preserve the pylorus 
(262 patients, 41.1%), 8 always section the gastric antrum (13 patients, 17.7%), 
while 7 used both techniques (261 patients, 41%).
Pylorus preservation in oncological cases is a controversial topic; it was com-
pared with the Whipple technique without significant differences between the two 
techniques in terms of overall survival (p = 0.11), in-hospital mortality (p = 0.18) 
and morbidity (p = 0.69), incidence of postoperative pancreatic fistula (POPF; 
p = 0.63), biliary leakage (BL; p = 0.82), post-pancreatectomy hemorrage (PPH; 
p = 0.53), or delayed gastric emptying (DGE; p = 0.16) [32]. Pylorus-preservation 
Figure 3. 
Pancreatic neck section using ultrasonic scissors.
Figure 4. 
Gastroduodenal artery closure using clips.
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was associated with a shorter operative time (p = 0.0004) and a reduced intraop-
erative blood loss (p = 0.00001).
There is a lack of data about laparoscopic “artery first approach” to PD and total 
mesopancreas excision (TMpE), because no details about this important topics were 










Great variability in the reconstructive phase is reported in the literature, both in 
materials (type of suture) and in fashioning anastomoses.
The management of the pancreatic stump represents one of the most important 
steps of the entire procedure [33, 34], especially when dealing with a soft gland, as 
it is one of the main risk factors for the development of a POPF [35, 36].
Pancreaticojejunostomy (PJ; 84% of cases; Figures 6 and 7) and pancreatico-
gastrostomy (PG; 9.8% of cases) are the most commonly performed anastomo-
ses; on the other hand, the duct occlusion has mostly been abandoned (6.8% of 
cases) [31].
In order to reduce the risk of POPF, the majority of the authors (72.8%) posi-
tioned a stent in the Wirsung, either routinely or selectively; the pancreatic anas-
tomosis was in most cases performed with a double layer (90.6%) and interrupted 
sutures (74.6%).
The gastro/duodenal-jejunal (GJ/DJ) anastomosis was antecolic in 76.3% of cases 
(Figure 8), retromesenteric in 13.4% of cases, and retrocolic in 10.2% of cases.
The majority of GJ and DJ anastomoses were handsewn (n = 491/566; 86.7%); 
mechanical anastomoses using stapler were performed in only 13.2% of cases and 
always to perform GJ anastomosis.
In a randomized multicentric study on 440 patients, Keck et al. [37] compared 
the outcomes of PG vs. PJ: although POPF rate was 20%, without significant dif-
ferences between the two techniques, the rate of anastomotic bleeding was higher 
for PG.
Surprisingly in a meta-analysis [38] based on 676 patients underwent to PD, 
a significantly lower rate of POPF was found in favor of PG, while there were no 
differences in the incidence of BL, PPH, or DGE between the two anastomoses.
4. Postoperative outcomes
4.1 Short-term outcomes
Despite the technical and technological progress made in recent years, postop-





The most frequent postoperative complications for PD are DGE (19–23% of 
cases), POPF (9–18%), intra-abdominal abscess (9–10%), and intra-abdominal or 
GI bleeding (1–8%) [40].
Many authors questioned the possibility to improve postoperative outcomes 
through the use of mini-invasiveness.
Compared to open PD, LPD has been found to require longer operative time  
[30, 41–43] (Tables 1 and 2); however, it leads to
• reduce intraoperative blood loss and the need for transfusions [6, 26, 30, 41, 
43–45]
• reduce postoperative pain [30]
• reduce intensive care unit (ICU) monitoring [42].
• reduce length of hospitals stay (LOS) [6, 30, 41–43, 45, 46] with differences 
varying between 2 and 5 days.
• reduce number of unscheduled readmissions [46].
• Thirty-day mortality and morbidity, including POPF, DGE, PPH, BL, and 
surgical site infection (SSI), are comparable between laparoscopic and open 
PD [30, 42–47].
4.2 Oncological outcomes
Regarding oncological radicality, laparoscopic PD appears to be at least noninfe-
rior to open PD.
Considering tumors of similar size and histological type, the number of har-
vested lymph nodes and the rate of negative resection margins have been found 
to be either comparable [20, 30, 45, 46, 48] between laparoscopic and open PD or 
superior in laparoscopic PD [6, 26, 41–43].











VL Op VL Op VL Op VL Op VL Op
Stauffer 2016 58 193 375 518 250 600 6 9 — —
Sharpe 2015 384 4037 nr nr nr nr 10 12 5.2 3.7
Song 2015 104 576 482 348 570 609 14 19 — —
Speicher 2014 25 84 381 326 200 425 8 10 — 1.2
Dokmak 2014 46 46 342 264 368 293 23 25 2 —
Croome 2014 108 214 379 387 492 866 6 9 1 2
Mesleh 2013 75 nr 551 nr nr nr 7 nr — nr
Asbun 2012 53 215 541 401 195 1032 8 12 5.7 8.8
Abbreviations: N, number; min, minutes; Intraop, intraoperative; Postop, postoperative; VL, laparoscopic; Op, open.
Table 1. 
Postoperative outcomes: comparison between laparoscopic and open PD.
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Overall survival between laparoscopic and open PD is comparable [6, 30, 45]. 
However, the reduction in postoperative pain and physical impairment, paired with 
the reduced rate of surgical site complications, may allow for a broader access to 
adjuvant chemotherapy and an earlier start of treatment in patients who underwent 
laparoscopic PD [11, 49].
Current studies comparing laparoscopic PD vs. open PD have been criticized 
because they may suffer from selection bias, as many of them excluded patients 
with vascular involvement, high intraoperative risk, and multiple previous abdomi-
nal operations, all of which have higher chances of undergoing an open procedure.
However, the results from Croome et al. [6] and the review from Wang et al. [43] 
showed promising results also in complex cases, which required vascular resections.
5. Learning curve
The learning curve for LPD is particularly steep and represents an obstacle to a 
more widespread use of the procedure; it seems that learning curve can be short-
ened with specific training strategies, e.g., ex vivo training, proctoring, and simula-
tion in loco.
The majority of studies about surgical learning curves define it as the number of 
procedures needed to achieve a decrease in operative time and blood loss and in the 
number of conversions.
With increased experience in those kinds of procedures, the surgeon is also able 
to deal laparoscopically with more technical complex situations, such as vascular 
resections (portal, mesenteric, and arterial), without increasing postoperative 
complications.
As shown in the review published by De Rooij et al. [12], there are three strate-
gies to learn how to carry out PD completely laparoscopically (i.e., not only the 
demolitive phase, which is more commonly performed laparoscopically, but also the 
reconstructive one, which represents a considerable obstacle for some).
The first strategy consists of tutoring. The second one is a hybrid approach, i.e., 
performing the demolitive phase through laparoscopy and the reconstructive phase 
Author Year Compl rate 
(CD > 3)
POPF rate PPH rate Median 
n of LNs 
harvested
R0 rate Reop rate
VL Op VL Op VL Op VL Op VL Op VL Op
Stauffer 2016 22 30 8 9 7 4 27 17 80 84 2 6
Sharpe 2015 nr nr nr nr nr nr 16 18 80 74 nr nr
Song 2015 7.5 5.4 6.5 6.5 nr nr 15 16 72 81 nr nr
Speicher 2014 nr nr 16 22.6 nr nr 14.5 12 83.3 78.6 8.7 10.7
Dokmak 2014 28 20 44 32 24 7 20 23 60 50 24 11
Croome 2014 6 14 11 12 7 6 21.4 20.1 77.8 76.6 nr nr
Mesleh 2013 31 31 9 6 nr nr nr nr nr nr 2 4
Asbun 2012 24.5 24.7 7.1 5.1 9.4 5.6 23.4 16.8 95 83 3.8 7
Abbreviations: Compl, complication; CD, Clavien-Dindo; POPF, postoperative pancreatic fistula; 
PPH, postpancreatectomy hemorrage; LNs, lymph nodes; Reop, reoperation; VL, laparoscopic; Op, open.
Table 2. 
Postoperative outcomes: comparison between laparoscopic and open PD.
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through a service minilaparotomy. The third one is also a hybrid approach, but the 
reconstructive phase is carried out robotically.
Each strategy has its own learning curve and needs to be performed only in 
specialized centers with high volumes of pancreatic surgeries to avoid unnecessar-
ily high rates of morbidity and mortality. Recent studies suggest that using hybrid 
techniques before performing the procedure completely laparoscopically might be 
useful. A cut off of 10 hybrid procedures is considered enough to start with full 
laparoscopy, although 50 hybrid procedures are required for significant improve-
ments in operative outcomes to appear/significant improvements in operative 
outcomes appear after 50 hybrid procedures.
A study by Speicher et al. [41] shows that laparoscopic PD’s learning curve goes 
through a slow and difficult initial phase (first 10 cases), a much faster improve-
ment phase (10–20 cases), and finally a plateau with a slow but steady improvement 
with time (after 50 cases).
However, these considerations can only be applied to surgeons with great exper-
tise in open PD and in advanced laparoscopic surgery; it is often difficult to satisfy 
both conditions, as many centers with high volumes of pancreatic surgeons do not 
have high volumes of laparoscopic surgery and vice versa.
Many years are required to overcome the learning curve and reach an adequate 
outcome level [50]. Pancreatic surgery should be centralized in dedicated centers, as 
this has been shown in many studies to improve outcomes [51, 52].
A review by Gumbs et al. [53] that analyzed 285 LPDs shows that the length of 
hospital stay and the operative time for the procedure decrease proportionally to the 
higher volume of cases of the center.
Different studies show that, as one moves along the learning curve, there is a 
decrease in operative time, blood loss, morbidity, and open conversions, resulting 
in a reduced length of hospital stay.
Kim et al. [24] analyzed 100 consecutive cases of pylorus-preserving LPD, of 
which all performed by the same surgeon and divided them in three time periods. 
With increased experience, operative time decreased from 9.8 hours in the first-
time period to 6.6 in the third. Length of hospital stay went from 20.4 to 11.5 days. 
Morbidity, including pancreatic fistula, intraoperative bleeding, delayed gastric 
emptying, and ileus, decreased from 33.3 to 17.6%.
Similar results, demonstrating an improvement in the surgical outomes increas-
ing the learning curve, also reported by Speicher et al. [41], with diminished opera-
tive time and blood loss with increased experience, and Song et al. [30].
Song et al. divided LPD’s cases into two cohorts (the first 47 consecutive cases 
vs. the next 50 cases). The second cohort had decreased operative time (399.4 vs. 
566.5 minutes, p < 0.0001), decreased intraoperative blood loss (503 vs. 685 cc, 
p = 0.018), and decreased length of hospitals stay (11.2 days vs. 17.3, p < 0.001).
Another cohort study shows that rates of postoperative pancreatic fistulas 
diminished from 36 to 18% after only 11 LPDs [1]. Other study also confirmed that 
morbidity is inversely proportional to the number of procedures performed in a 
single center [9, 20, 30].
Mortality also decreased with an increase in experience [54]; analyzing a 
national database with over 7000 patients who underwent PD from 2010 to 2011, 
higher 30-day mortality with LPD than with open PD was found. However, this 
result only applied to those centers with less than 10 LPDs in 2 years, where 30-day 
mortality was twice that of open PD. In centers with more than 10 LPDs, 30-day 
mortality was similar in laparoscopic and open procedures.
The dramatic improvement shown by these authors as they progress along the 
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6. Costs
Most of the financial benefit of laparoscopic vs. open PD is attributed to the 
reduced length of hospital stay [15, 17, 20, 30]. However, laparoscopy significantly 
increases operative time (usually by 2 hours) [30] and requires expensive materi-
als with an increase in cost of 35%, p < 0.0001, both of which lead to increased 
costs [30].
Speicher et al. and Mesleh et al. compared open vs. laparoscopic PD costs 
[41, 44]. They concluded that total costs were comparable. According to Speicher 
et al. [41], laparoscopic PD costs 24,590 dollars vs. 19,720 dollars in open technique 
(p = 0.19).
According to Mesleh et al. [44], laparoscopic PD is significantly more expen-
sive (p < 0.0001) than open PD, due to the cost of the surgical material and the 
increased operative time (551 vs. 355 minutes).
Morbidity and postoperative length of hospital stay were comparable and did 
not influence the overall cost. However, the post-operative management for open 
PD is slightly more expensive than laparoscopic PD when single categories are taken 
into account (expenses for nursing, anaesthesia, drugs, labs, and imaging).
As recovery expenses represent 65–70% of the overall cost, the decreased 
postoperative cost of laparoscopic PD balances out its increased intra-operative cost 
when compared to open PD.
7. Conclusions
LPD is a safe, standardizable, and oncologically adequate surgical technique, but 
only if performed by surgeons with extensive experience both in pancreatic surgery 
and in laparoscopy and, at least at the beginning of the learning curve, on appropri-
ately selected cases.
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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